Neutrogena Study Supports High SPF Labeling; Will FDA Take Off Its Cap?

As the release of FDA's final sunscreen monograph looms, Johnson & Johnson is again expressing concern about the agency's proposed cap on sun protection factors cited on product labeling, supporting its position with research comparing two formulas of different SPF values

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from HBW Insight